Clinical Trials on Metastatic Malignant Uveal Melanoma
Total 1713 results
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Inge Marie SvaneCompleted
-
Nantes University HospitalUMR892Completed
-
University of RegensburgUnknown
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States
-
Cliniques universitaires Saint-Luc- Université...TerminatedMetastatic MelanomaBelgium
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Western Regional Medical CenterTerminated
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)Withdrawn
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Hoag Memorial Hospital PresbyterianCompletedMetastatic MelanomaUnited States
-
Eisai Inc.Completed
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Duke UniversityTerminatedMetastatic MelanomaUnited States
-
University of Massachusetts, WorcesterCompleted
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
California Pacific Medical Center Research InstituteCompletedMetastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Pain TherapeuticsCompleted
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Charite University, Berlin, GermanyUnknown
-
University of TurkuCompletedMetastatic MelanomaFinland
-
Sheba Medical CenterRecruitingMalignant Melanoma Stage IVIsrael
-
Baylor Research InstituteCompletedMalignant Melanoma Stage IVUnited States
-
Vastra Gotaland RegionCompletedMelanoma Stage Iv | Melanoma Metastatic | Abdominal TumorSweden
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
IO BiotechMerck Sharp & Dohme LLC; Syneos HealthActive, not recruitingMetastatic Melanoma | Unresectable MelanomaHungary, Spain, United Kingdom, Australia, France, Italy, United States, Denmark, Germany, Israel, Czechia, Belgium, Netherlands, Turkey, Poland, South Africa
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline; Tesaro, Inc.Completed
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
Pierre Fabre MedicamentBiotrialCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Inge Marie SvaneRecruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Yale UniversityAstraZenecaWithdrawn
-
NewLink Genetics CorporationCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Acrotech Biopharma Inc.CompletedMalignant MelanomaUnited States
-
Assistance Publique - Hôpitaux de ParisUnknown